Zeke Capital Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,844
Closed -$327K 271
2020
Q1
$327K Sell
1,844
-3,021
-62% -$569K 0.09% 128
2019
Q4
$930K Buy
4,865
+2,680
+123% +$483K 0.08% 219
2019
Q3
$368K Sell
2,185
-3,304
-60% -$538K 0.03% 415
2019
Q2
$919K Sell
5,489
-1,031
-16% -$143K 0.09% 204
2019
Q1
$955K Buy
6,520
+3,832
+143% +$556K 0.09% 191
2018
Q4
$359K Sell
2,688
-3,063
-53% -$502K 0.03% 402
2018
Q3
$1.09M Buy
5,751
+24
+0.4% +$4.41K 0.09% 224
2018
Q2
$955K Sell
5,727
-661
-10% -$106K 0.09% 192
2018
Q1
$1.07M Sell
6,388
-3,884
-38% -$651K 0.1% 181
2017
Q4
$1.68M Buy
10,272
+6,388
+164% +$1.15M 0.18% 100
2017
Q3
$796K Buy
3,884
+1,174
+43% +$273K 0.11% 151
2017
Q2
$659K Buy
2,710
+147
+6% +$34.5K 0.13% 102
2017
Q1
$612K Buy
2,563
+700
+38% +$163K 0.13% 91
2016
Q4
$391K Buy
+1,863
New +$386K 0.11% 104

Other funds holding AGN

Zeke Capital Advisors's AGN Position: Q2 2020 in Review

Zeke Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,844 shares — an estimated $327K sold.

Zeke Capital Advisors first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $1.68M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Zeke Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Zeke Capital Advisors sold 1,844 Allergan plc shares in Q2 2020, an estimated $327K.
  • Zeke Capital Advisors first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Zeke Capital Advisors's Allergan plc position peaked at $1.68M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Zeke Capital Advisors's 13F filing for Q2 2020, filed 21 Jul 2020.